Suppr超能文献

经皮治疗单囊型与多囊型肝包虫囊肿

Percutaneous treatment of univesicular versus multivesicular hepatic hydatid cysts.

作者信息

Zerem E, Jusufovic R

机构信息

The Interventional Ultrasonography Department, University Clinical Center, Tuzla, Bosnia and Herzegovina.

出版信息

Surg Endosc. 2006 Oct;20(10):1543-7. doi: 10.1007/s00464-006-0135-z. Epub 2006 Aug 1.

Abstract

BACKGROUND

Percutaneous drainage has been used successfully to treat hepatic hydatid cysts. This study aimed to analyze the results of this method in the treatment of univesicular and multivesicular hepatic hydatid cysts.

METHODS

Ultrasound-guided percutaneous drainage was used to treat 72 patients (44 women and 28 men; average age, 46.8 +/- 17.7 years) with hepatic hydatidosis. Of these 72 patients, 57 had one cyst, 7 had two cysts, and 8 had three cysts. Albendazole (10 mg per kg of body weight daily for 8 weeks) was administered to all the patients. Serial assessments included clinical and biochemical examinations, ultrasonography, and serologic tests for echinococcal antibody titers.

RESULTS

During the follow-up period, the mean cyst diameter decreased from 83.3 +/- 38.6 mm to 11.1 +/- 16.0 mm (p < 0.001) in the multivesicular group (27 cysts) and from 65.5 +/- 27.5 to 5.9 +/- 13.0 mm (p < 0.001) in the univesicular group (68 cysts). The final cyst diameter did not differ significantly between the two groups (p = 0.1). The findings showed that 81% of the cysts in the univesicular group and 63% in the multivesicular group disappeared (p = 0.12). The mean hospital stay was 4.8 +/- 2.9 days in the univesicular group and 6.1 +/- 4.7 days in the multivesicular group (p < 0.001). After an initial rise, the echinococcal-antibody titers fell progressively, and at the last follow-up evaluation were negative (<1:160) for 43 patients (94%) in the univesicular group and 19 patients (73%) in the multivesicular group (p = 0.03). Mild nonfatal complications were experienced by 24 patients (33%).

CONCLUSIONS

Percutaneous drainage combined with albendazole therapy is an effective and safe method for managing hydatid cysts of the liver that requires a short hospital stay. Disappearance of the cysts depends on cyst size. Multivesicular cysts have a more complicated course, a slower disappearance, and a higher incidence of positive echinococcal-antibody titers. Abscess formed after the procedure can be treated successfully by percutaneous drainage.

摘要

背景

经皮引流已成功用于治疗肝包虫囊肿。本研究旨在分析该方法治疗单房性和多房性肝包虫囊肿的效果。

方法

采用超声引导下经皮引流治疗72例肝包虫病患者(44例女性和28例男性;平均年龄46.8±17.7岁)。这72例患者中,57例有1个囊肿,7例有2个囊肿,8例有3个囊肿。所有患者均给予阿苯达唑(每日10 mg/kg体重,共8周)。连续评估包括临床和生化检查、超声检查以及棘球蚴抗体滴度的血清学检测。

结果

在随访期间,多房性囊肿组(27个囊肿)的囊肿平均直径从83.3±38.6 mm降至11.1±16.0 mm(p<0.001),单房性囊肿组(68个囊肿)从65.5±27.5 mm降至5.9±13.0 mm(p<0.001)。两组最终囊肿直径差异无统计学意义(p = 0.1)。结果显示,单房性囊肿组81%的囊肿和多房性囊肿组63%的囊肿消失(p = 0.12)。单房性囊肿组平均住院时间为4.8±2.9天,多房性囊肿组为6.1±4.7天(p<0.001)。棘球蚴抗体滴度最初升高后逐渐下降,在最后一次随访评估时,单房性囊肿组43例患者(94%)和多房性囊肿组19例患者(73%)的抗体滴度为阴性(<1:160)(p = 0.03)。24例患者(33%)出现轻度非致命性并发症。

结论

经皮引流联合阿苯达唑治疗是一种治疗肝包虫囊肿有效且安全的方法,住院时间短。囊肿的消失取决于囊肿大小。多房性囊肿病程更复杂,消失更慢,棘球蚴抗体滴度阳性发生率更高。术后形成的脓肿可通过经皮引流成功治疗。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验